DALLAS, June 30, 2022 — Ann Marie Schmidt, M.D., has been selected as the new editor-in-chief of Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB), a peer-reviewed journal published by the American Heart Association, effective tomorrow, July 1, 2022. She most recently served as a senior deputy editor of ATVB and succeeds previous Editor-in-Chief Alan Daugherty, Ph.D., D.Sc., FAHA, who has led the journal since July 2, 2012.
“Thank you, Dr. Daugherty, for your outstanding and steady leadership of the ATVB journal for the past 10 years.” said Eldrin F. Lewis, M.D., M.P.H., FAHA, chair of the American Heart Association’s Scientific Publishing Committee. “I’m proud to announce Dr. Schmidt as the new editor-in-chief of ATVB. In her time as senior deputy editor, Dr. Schmidt has worked diligently to preserve the integrity of ATVB within the scientific and medical communities. She is a passionate researcher with an incredible knowledge about the intersection between cardiovascular and metabolic disease. I am certain ATVB will continue to thrive under her leadership.”
Dr. Schmidt is a well-respected, published researcher who, for more than 30 years, has been dedicated to exploring the pathology of receptors for advanced glycation end products (RAGE) in diabetes, obesity and innate immunity. RAGE was initially discovered in Dr. Schmidt’s laboratory when she was at Columbia University, and she continues to lead investigations into the role of RAGE in diabetes and obesity and their cardiovascular and metabolic complications. Dr. Schmidt’s work is integral to our understanding of how inextricably heart disease is intertwined with diabetes, and more recently she has also found links between RAGE and neurodegenerative diseases such as Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS).
Dr. Schmidt is the Dr. Iven Young Professor of Endocrinology in the department of medicine; professor in the department of biochemistry and molecular pharmacology; professor in the department of pathology at NYU Grossman School of Medicine and the director of the Diabetes Research Program at NYU Langone Health, both in New York City.
“It’s a great privilege to be named the new editor-in-chief of ATVB and to have the opportunity to lead the journal in serving the cardiovascular scientific community by publishing the best research covering arteriosclerosis, thrombosis and vascular biology,” said Dr. Schmidt. “In my new role, I am committed to maintaining high standards and ensuring the diversity of topic areas, so that the journal remains a premier venue for the latest discoveries from around the world.”
“One of my goals in this new role will be to understand the opportunities across AHA journals to engage individuals whose research is deeply embedded in the quest for health equity and overall emphasis on fostering diversity,” Dr. Schmidt explained. “I’m excited to broaden ATVB’s interest areas, such as in metabolism, bioengineering, inter-organ cross-talk and in control of gene transcription.”
Dr. Schmidt earned undergraduate degrees and a medical degree from the NYU School of Medicine at New York University. She completed her internship, residency and fellowships in medical oncology and hematology at New York University Medical Center, Bellevue Hospital Center, and she is board certified in internal medicine. Her post-doctoral research fellowship was in the department of physiology and cellular biophysics at Columbia University, where she also served in a number of roles including chief of the division of surgical science in the department of surgery. Dr. Schmidt returned to NYU in 2010 where she founded the Diabetes Research Program along with Ravichandran Ramasamy, Ph.D. This laboratory group studies the biochemical and molecular mechanisms of the complications of diabetes, particularly the links among hyperglycemia, inflammation and diabetic tissue damage.
Her work has received several awards including the Special Recognition Award from the Vascular Biology Council on Arteriosclerosis, Thrombosis and Vascular Biology for the American Heart Association in 2015; the Gill Heart and Vascular Institute Award for Outstanding Contributions to Cardiovascular Research from the University of Kentucky in 2019; the Basic Research Prize from the American Heart Association in 2020; and the American Heart Association’s ATVB Women’s Leadership Committee Award for Outstanding Mentorship of Women in 2021. Dr. Schmidt’s work has been published in 634 peer-reviewed publications, invited articles and chapters, and abstracts.
Statements and conclusions of studies published in the American Heart Association’s scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
- Access the journal, Arteriosclerosis, Thrombosis, and Vascular Biology
- AHA news release: Ann Marie Schmidt, M.D., of NYU to be recognized with AHA’s 2020 Basic Research Prize
- Follow AHA/ASA news on Twitter @HeartNews
- Follow news from the AHA’s ATVB journal @ATVBAHAJournals
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
Contact Information: Ann Marie Schmidt, M.D., may be reached by contacting the American Heart Association.
For Media Inquiries: 214-706-1173; AHACommunications@heart.org
Michelle Kirkwood: 703-457-7838; Michelle.Kirkwood@heart.org
Maggie Francis: 214-706-1382; Maggie.Francis@heart.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)